Product Images Gabapentin

This is a description of Gabapentin tablets with NDC code 70934-950-30. The remaining text is not readable and cannot provide any useful information.*

This appears to be a medical formula for calculating the Creatinine Clearance (CLCr) of a female patient using their serum creatinine levels (mg/dL). However, without more context, it is difficult to provide a more specific description or interpretation.*

The text contains information about a clinical trial with a 4-week dose titration period and a 4-week fixed dose period. There are two treatment groups: placebo and gabapentin at a dose of 3600 mg/day. The text also displays a mean pain score of 10, but no context is provided for this score. There is some unreadable text in the form of symbols and characters.*

The text provides a table with four columns showing the mean pain score for participants during a four-week fixed dose period using different treatments. The treatments include a placebo and two doses of Gabapentin (1800mg/day and 2400mg/day). The table also includes a baseline column and data measured at week 1. No further information is available.*

This is a chart showing the proportion of responders in controlled PHN studies. It includes percentages ranging from 0% to 100%, with specific percentages shown for different treatments such as GBP 3600 and PBO, as well as different study groups. The figure also includes a note indicating that a p-value of less than 0.001 was observed in one or more of the studies.*